Dr. James Emrys Pfost

DDS | Dentist



  
  9502 W Fairview Ave, Boise
  Idaho, 83704-8103

  208-377-2223    208-672-0035 Maps & Directions
Dr. James Emrys Pfost is a Boise, Idaho based Dentist who is specialized in General Practice Dentistry. He may accept the Medicare-approved amount. Patients may be billed for more than the Medicare deductible and coinsurance. His current practice location is 9502 W Fairview Ave, Boise. Patients can reach him at 208-377-2223.
Dr. James Emrys Pfost is the primary dental care provider for patients of all ages. He is responsible for the diagnosis, treatment, management and overall coordination of services related to patients' oral health needs.
Complete Profile:
Dr. James Emrys Pfost speciality, credentials, practice address, contact phone number and fax are as below. Patients can directly walk in or can call on the below given phone number for appointment.
Name: Dr. James Emrys Pfost
Specialization: Dentist
Gender:Male
Credentials: DDS
Accepts Medicare Assignment:May Accept
Practice Address:9502 W Fairview Ave, Boise,
Idaho, 83704-8103
Phone:208-377-2223
Fax:208-672-0035
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
PAC ID: 9032407770
Enrollment ID: I20161012000420
NPI Number: 1295755932
NPI Enumeration Date: 19 Jul, 2006
NPI Last Update On: 23 Jul, 2014

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 9502 W Fairview Ave,
Boise, Idaho
Zip: 83704-8103
Phone Number: 208-377-2223
Fax Number: 208-672-0035
Patients can reach Dr. James Emrys Pfost at 9502 W Fairview Ave, Boise, Idaho or can call to book an appointment on 208-377-2223. Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.

Comments/ Reviews: